Munisvaradass, R.; Kumar, S.; Govindasamy, C.; Alnumair, K.S.; Mok, P.L.
Human CD3+ T-Cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells. Int. J. Mol. Sci. 2017, 18, 1797.
https://doi.org/10.3390/ijms18091797
AMA Style
Munisvaradass R, Kumar S, Govindasamy C, Alnumair KS, Mok PL.
Human CD3+ T-Cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells. International Journal of Molecular Sciences. 2017; 18(9):1797.
https://doi.org/10.3390/ijms18091797
Chicago/Turabian Style
Munisvaradass, Rusheni, Suresh Kumar, Chandramohan Govindasamy, Khalid S. Alnumair, and Pooi Ling Mok.
2017. "Human CD3+ T-Cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells" International Journal of Molecular Sciences 18, no. 9: 1797.
https://doi.org/10.3390/ijms18091797
APA Style
Munisvaradass, R., Kumar, S., Govindasamy, C., Alnumair, K. S., & Mok, P. L.
(2017). Human CD3+ T-Cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells. International Journal of Molecular Sciences, 18(9), 1797.
https://doi.org/10.3390/ijms18091797